These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6842390)

  • 21. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation about wettability, water absorption or swelling of excipients through various methods and the correlation between these parameters and tablet disintegration.
    Yang B; Wei C; Yang Y; Wang Q; Li S
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1417-1425. PubMed ID: 29557692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of the critical points of experimental HPMC-NaCMC hydrophilic matrices.
    Contreras L; Melgoza LM; Villalobos R; Caraballo I
    Int J Pharm; 2010 Feb; 386(1-2):52-60. PubMed ID: 19900524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carboxymethylcellulose: effect of degree of polymerization and substitution on tablet disintegration and dissolution.
    Shah NH; Lazarus JH; Sheth PR; Jarowski CI
    J Pharm Sci; 1981 Jun; 70(6):611-3. PubMed ID: 7252800
    [No Abstract]   [Full Text] [Related]  

  • 25. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
    Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
    Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Miniaturized approach for excipient selection during the development of oral solid dosage form.
    Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
    J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surrogate functionality of celluloses as tablet excipients.
    Díaz Ramírez CC; Robles LV
    Drug Dev Ind Pharm; 2010 Dec; 36(12):1422-35. PubMed ID: 20545518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new model describing the swelling and drug release kinetics from hydroxypropyl methylcellulose tablets.
    Siepmann J; Podual K; Sriwongjanya M; Peppas NA; Bodmeier R
    J Pharm Sci; 1999 Jan; 88(1):65-72. PubMed ID: 9874704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thixotropic behavior of a microcrystalline cellulose-sodium carboxymethylcellulose gel.
    Dolz-Planas M; González-Rodriguez F; Belda-Maximino R; Herraez-Dominguez JV
    J Pharm Sci; 1988 Sep; 77(9):799-801. PubMed ID: 3225776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained release tablets based on chitosan and carboxymethylcellulose sodium.
    Inouye K; Machida Y; Nagai T
    Drug Des Deliv; 1987 May; 1(4):297-305. PubMed ID: 3509339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interactions between macromolecular excipients and drugs. 23. Inhibition of binding and liberation of aminoglycoside antibiotics and capreomycin by sodium carboxymethylcellulose].
    Keipert S; Schulz K
    Pharmazie; 1981 Dec; 36(12):869-70. PubMed ID: 6173889
    [No Abstract]   [Full Text] [Related]  

  • 32. Matrices containing NaCMC and HPMC 1. Dissolution performance characterization.
    Conti S; Maggi L; Segale L; Ochoa Machiste E; Conte U; Grenier P; Vergnault G
    Int J Pharm; 2007 Mar; 333(1-2):136-42. PubMed ID: 17207943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Observations on the electrolyte sensitivity of CMC as tablet disintegrant.
    Ujfalussy G; Erdös S
    Pharmazie; 1982 Sep; 37(9):673-4. PubMed ID: 7146078
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of powder blend uniformity: Comparison of real-time NIR blend monitoring with stratified sampling in combination with HPLC and at-line NIR Chemical Imaging.
    Bakri B; Weimer M; Hauck G; Reich G
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):78-89. PubMed ID: 26455421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Modification of alpha-chymotrypsin by soluble carboxymethyl cellulose and sorption immobilization of CMC-chymotrypsin].
    Kinstler OB; Kozlov LV
    Biokhimiia; 1977 Sep; 42(9):1674-81. PubMed ID: 21001
    [No Abstract]   [Full Text] [Related]  

  • 36. Matrices containing NaCMC and HPMC 2. Swelling and release mechanism study.
    Conti S; Maggi L; Segale L; Ochoa Machiste E; Conte U; Grenier P; Vergnault G
    Int J Pharm; 2007 Mar; 333(1-2):143-51. PubMed ID: 17240091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Swelling, erosion and drug release characteristics of salbutamol sulfate from hydroxypropyl methylcellulose-based matrix tablets.
    Chaibva FA; Khamanga SM; Walker RB
    Drug Dev Ind Pharm; 2010 Dec; 36(12):1497-510. PubMed ID: 20528615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIGH SHEAR GRANULATION PROCESS: ASSESSING IMPACT OF FORMULATION VARIABLES ON GRANULES AND TABLETS CHARACTERISTICS OF HIGH DRUG LOADING FORMULATION USING DESIGN OF EXPERIMENT METHODOLOGY.
    Fayed MH; Abdel-Rahman SI; Alanazi FK; Ahmed MO; Tawfeek HM; Ali BE
    Acta Pol Pharm; 2017 Mar; 74(2):551-564. PubMed ID: 29624260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma.
    Chen YD; Liang ZY; Cen YY; Zhang H; Han MG; Tian YQ; Zhang J; Li SJ; Yang DS
    Drug Des Devel Ther; 2015; 9():5815-25. PubMed ID: 26640367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cicatrol-type ointments].
    Verbuţă A; Cojocaru I; Olaru N; Lazăr M; Lazăr D; Alexandrescu G; Mîndreci I
    Rev Med Chir Soc Med Nat Iasi; 1986; 90(1):161-4. PubMed ID: 3764167
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.